We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




3D Printed Diagnostic Device Rapidly Detects Anemia

By LabMedica International staff writers
Posted on 07 Mar 2016
A new biomedical device has been developed using 3D printers to create a low cost, point-of-care device that can quickly detect anemia, a condition in which the blood does not have enough healthy red blood cells to transport oxygen to the body's organs. More...


Point-of-care devices give the user fast, easy-to-understand results from a test performed outside of a laboratory, such as a blood glucose test or pregnancy test and identifying a blood disorder may be as easy as running a blood sample from a finger prick under a smartphone.

Scientists at Kansas State University (Olathe, KS, USA) made the device with a Projet 1200 3D printer (3DSystems; Rock Hill, SC, USA) and designed it to detect anemia for individuals who have limited access to health care, such as those living in developing countries. Anemia affects two billion people worldwide, including more than half of preschool children and pregnant women in developing countries and at least 30% of children and women in some industrialized nations.

The device consists of 3D printed clear plastic slides containing microfluidics that attach to a smartphone. The user adds a drop of their blood to a slide, which is used for a color scale-based test. The test results are produced in less than 60 seconds and can be read using a smartphone. A companion app is being developed with Steve Warren, PhD, an associate professor in electrical and computer engineering at Kansas State University, which could manage data from the blood sample and even send the results to a doctor.

Kim Plevniak, a master's student in biological and agricultural engineering, who worked on the device, said, “Anemia is a very prevalent condition in developing countries even though it is easily treated with iron supplements or vitamins and can be prevented with a healthy diet. Often in these developing countries people will have much easier access to smartphones than they will to doctors and trained medical professionals.”

Related Links:

Kansas State University 
3Dsystems



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
Gold Member
Automatic Hematology Analyzer
CF9600
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The test combines RNA signals from the tumor-immune microenvironment to predict treatment response, rather than relying on a single marker such as PD-L1 expression.(Image Credit: Adobe Stock)

RNA-Based Test Predicts Immunotherapy Response in Non-Small Cell Lung Cancer

Non-small cell lung cancer (NSCLC) represents the largest U.S. patient population eligible for immune checkpoint inhibitor therapy. Treatment selection often relies on PD-L1 expression, but a single protein... Read more

Immunology

view channel
Image Credit: Adobe Stock

Immune Profiling Identifies Early Maternal Autoantibodies Linked to Preterm Birth Risk

A typical pregnancy lasts about 40 weeks, but labor begins prematurely in roughly one in 10 pregnancies. Preterm birth is the leading cause of newborn death worldwide, yet its underlying causes and which... Read more

Industry

view channel
Image Credit: iStock

Global TB Summit Connects Diagnostic Testing With Prevention and Clinical Care

Tuberculosis remains a major global infectious disease challenge despite declining deaths. In 2024, an estimated 10.7 million people worldwide developed the disease and nearly 1.2 million died from it.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.